Diabetic Neuropathy

OBJECTIVE To determine the relationships among large, small, and autonomic fiber neurophysiological measures in a cross-sectional study of patients with diabetes. RESEARCH DESIGN AND METHODS We assessed 130 individuals: 25 healthy subjects and 105 subjects with diabetes. Subjects were classified by the presence or absence of neuropathy by physical examination. All subjects underwent autonomic testing, nerve conduction studies, quantitative sensory testing, and nerve-axon reflex vasodilation in addition to quantifiable neurological examination and symptom scores. Correlation and cluster analysis were used to determine relationships between and among different neurophysiological testing parameters. RESULTS Results of neurophysiological tests were abnormal in patients with clinical evidence of diabetic neuropathy compared with results in healthy control subjects and in those without neuropathy (P < 0.01, all tests). The correlations among individual tests varied widely, both within (r range <0.5–>0.9, NS to <0.001) and between test groups (r range <0.2–>0.5, NS to <0.01). A two-step hierarchical cluster analysis revealed that neurophysiological tests do not aggregate by typical “small,” “large,” or “autonomic” nerve fiber subtypes. CONCLUSIONS The modest correlation coefficients seen between the different testing modalities suggest that these techniques measure different neurophysiological parameters and are therefore not interchangeable. However, the data suggest that only a small number of neurophysiological tests are actually required to clinically differentiate individuals with neuropathy from those without. The natural clustering of both patients and healthy control subjects suggests that variations in the population will need to be considered in future studies of diabetic neuropathy.

[1]  P. Lozeron,et al.  [Autonomic peripheral neuropathy]. , 2012, Presse medicale.

[2]  E. Feldman,et al.  Hyperlipidemia: a new therapeutic target for diabetic neuropathy , 2009, Journal of the peripheral nervous system : JPNS.

[3]  E. Feldman,et al.  Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy , 2009, Diabetes.

[4]  T. Lyons,et al.  Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  Karen L Price,et al.  Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes , 2007, Muscle & nerve.

[6]  A. Vinik,et al.  Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.

[7]  A. Veves,et al.  Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  A. Gordon Smith,et al.  Idiopathic neuropathy, prediabetes and the metabolic syndrome. , 2006, Journal of the neurological sciences.

[9]  R. Freeman,et al.  The evaluation of small fiber function-autonomic and quantitative sensory testing. , 2004, Neurologic clinics.

[10]  J C Arezzo,et al.  Quantitative sensory testing , 2003, Neurology.

[11]  R. Freeman,et al.  Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy , 2003, Neurology.

[12]  W. Litchy,et al.  Individual attributes versus composite scores of nerve conduction abnormality: Sensitivity, reproducibility, and concordance with impairment , 2003, Muscle & nerve.

[13]  F. Logerfo,et al.  Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. , 2001, Diabetes care.

[14]  D. Armstrong,et al.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. , 2000, Diabetes care.

[15]  B Stemper,et al.  Quantitative thermal perception testing in adults. , 1999, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[16]  V. Bril,et al.  Electrophysiological monitoring in clinical trials , 1998 .

[17]  R. Freeman,et al.  Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. , 1998, Diabetes.

[18]  V. Bril,et al.  Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group. , 1998, Muscle & nerve.

[19]  V. Bril,et al.  Comparison of a Neurothesiometer and Vibration in Measuring Vibration Perception Thresholds and Relationship to Nerve Conduction Studies , 1997, Diabetes Care.

[20]  M. B. Brown,et al.  Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial , 1996, Neurology.

[21]  M. Nathan,et al.  Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial , 1995, Annals of neurology.

[22]  J. Giurini,et al.  Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. , 1995, Diabetes research and clinical practice.

[23]  A. Veves,et al.  Comparison of Risk Factors for Foot Problems in Diabetic Patients Attending Teaching Hospital Outpatient Clinics in Four Different European States , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[24]  A. Veves,et al.  Painful Neuropathy and Foot Ulceration in Diabetic Patients , 1993, Diabetes Care.

[25]  David Yarnitsky,et al.  Quantitative Sensory Testing , 1992, Diabetes Care.